<p>(A) Prediction was assessed for the total number of samples. (B) Prediction was assessed in samples infected with HIV-1 subtype CRF02_AG or non-CRF02_AG strains.</p
Abstract Background HIV-1 subtype D infections have been associated with rapid disease progression a...
Background: Assessment of human immunodeficiency virus type 1 (HIV-1) coreceptor usage is required p...
Objectives: Geno2pheno[coreceptor] is a widely used tool for the prediction of coreceptor usage (vir...
Antiretroviral treatment of Human Immunodeficiency Virus type-1 (HIV-1) infections with CCR5-antagon...
Antiretroviral treatment of Human Immunodeficiency Virus type-1 (HIV-1) infections with CCR5-antagon...
Objective: The human immunodeficiency virus type 1 (HIV-1) currently infects over 30 million people ...
Abstract Background This study explored co-receptor usage and prediction of V3 genotyping algorithms...
International audienceGenotypic algorithms for prediction of HIV-1 coreceptor usage need to be evalu...
The use of CCR5 antagonists involves determination of HIV-1 tropism prior to initiation of treatment...
Objective: Integrating CCR5 antagonists into clinical practice would benefit from accurate assays o...
We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co-receptor us...
We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co-receptor us...
The acquired immunodeficiency syndrome (AIDS) is one of the biggest medical challenges in the world ...
and webPSSM. (5–20% FPR) and webPSSM-R5X4. For discordant samples, phenotypic outcome was retested ...
Genotypic tropism testing (GTT) has been developed largely on HIV-1 subtype B. Although a few report...
Abstract Background HIV-1 subtype D infections have been associated with rapid disease progression a...
Background: Assessment of human immunodeficiency virus type 1 (HIV-1) coreceptor usage is required p...
Objectives: Geno2pheno[coreceptor] is a widely used tool for the prediction of coreceptor usage (vir...
Antiretroviral treatment of Human Immunodeficiency Virus type-1 (HIV-1) infections with CCR5-antagon...
Antiretroviral treatment of Human Immunodeficiency Virus type-1 (HIV-1) infections with CCR5-antagon...
Objective: The human immunodeficiency virus type 1 (HIV-1) currently infects over 30 million people ...
Abstract Background This study explored co-receptor usage and prediction of V3 genotyping algorithms...
International audienceGenotypic algorithms for prediction of HIV-1 coreceptor usage need to be evalu...
The use of CCR5 antagonists involves determination of HIV-1 tropism prior to initiation of treatment...
Objective: Integrating CCR5 antagonists into clinical practice would benefit from accurate assays o...
We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co-receptor us...
We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co-receptor us...
The acquired immunodeficiency syndrome (AIDS) is one of the biggest medical challenges in the world ...
and webPSSM. (5–20% FPR) and webPSSM-R5X4. For discordant samples, phenotypic outcome was retested ...
Genotypic tropism testing (GTT) has been developed largely on HIV-1 subtype B. Although a few report...
Abstract Background HIV-1 subtype D infections have been associated with rapid disease progression a...
Background: Assessment of human immunodeficiency virus type 1 (HIV-1) coreceptor usage is required p...
Objectives: Geno2pheno[coreceptor] is a widely used tool for the prediction of coreceptor usage (vir...
DOI
Add to ORKG